Literature DB >> 28791818

Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.

Ewelina Litwińska1, Magdalena Litwińska2, Przemysław Oszukowski1, Krzysztof Szaflik2, Piotr Kaczmarek3.   

Abstract

BACKGROUND: Pre-eclampsia is a systemic disease connected with high maternal and fetal morbidity and mortality. Despite significant progress achieved in perinatal medicine, pre-eclampsia is still one of the most significant current problems in obstetrics.
OBJECTIVES: The aim of the study was to establish diagnostic algorithms for early and late pre-eclampsia (PE) and intrauterine growth restriction (IUGR).
MATERIAL AND METHODS: A total of 320 pregnant women between 11 + 0 and 13 + 6 weeks of gestation were recruited for a case-control study. The study group consisted of 22 patients with early PE, 29 patients with late PE and 269 unaffected controls. The following parameters were recorded: maternal history, mean arterial pressure (MAP), mean uterine artery pulsatility index (UtA-PI), and the concentrations of placental growth factor (PlGF), pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free β-hCG).
RESULTS: A multivariable stepwise logistic regression analysis indicated that the best screening model for the prediction of early PE is based on a combined analysis of maternal risk factors, UtA-PI and PlGF levels (sensitivity: 91%; specificity: 84%). The best screening model for the prediction of late PE is based on a combined analysis of maternal risk factors, UtA-PI and MAP (sensitivity: 85%; specificity: 83%). The most effective screening model for the prediction of IUGR is based on a combined analysis of maternal risk factors, UtA-PI and PlGF concentrations (sensitivity: 91%; specificity: 83%).
CONCLUSIONS: The integrated model of screening established in this study can be a valuable method to identify patients at increased risk of developing pre-eclampsia and related complications. The ability to predict the occurrence of pre-eclampsia in early pregnancy would enable maternal and fetal morbidity to be reduced through the introduction of strict obstetric surveillance as well as planned delivery in a reference center.

Entities:  

Keywords:  diagnostic algorithms; placental growth factor; pre-eclampsia

Mesh:

Substances:

Year:  2017        PMID: 28791818     DOI: 10.17219/acem/62214

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  4 in total

1.  Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?

Authors:  Manouk L E Hendrix; Judith A P Bons; Roy R G Snellings; Otto Bekers; Sander M J van Kuijk; Marc E A Spaanderman; Salwan Al-Nasiry
Journal:  Fetal Diagn Ther       Date:  2019-05-08       Impact factor: 2.587

2.  Personalized Model to Predict Small for Gestational Age at Delivery Using Fetal Biometrics, Maternal Characteristics, and Pregnancy Biomarkers: A Retrospective Cohort Study of Births Assisted at a Spanish Hospital.

Authors:  Peña Dieste-Pérez; Ricardo Savirón-Cornudella; Mauricio Tajada-Duaso; Faustino R Pérez-López; Sergio Castán-Mateo; Gerardo Sanz; Luis Mariano Esteban
Journal:  J Pers Med       Date:  2022-05-08

3.  Assessing the Role of Uric Acid as a Predictor of Preeclampsia.

Authors:  Ana I Corominas; Yollyseth Medina; Silvia Balconi; Roberto Casale; Mariana Farina; Nora Martínez; Alicia E Damiano
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

Review 4.  Unravelling the potential of angiogenic factors for the early prediction of preeclampsia.

Authors:  Juilee S Deshpande; Deepali P Sundrani; Akriti S Sahay; Sanjay A Gupte; Sadhana R Joshi
Journal:  Hypertens Res       Date:  2021-04-01       Impact factor: 3.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.